BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Valentino Trubiani Named Director of Galea Life Sciences


5/12/2009 11:33:21 AM

AVENTURA, FL--(Marketwire - May 12, 2009) -

Galea Life Sciences, Inc. maker of Nutraplete™, the first dietary supplement designed specifically for people living with HIV/AIDS, today announced that its Board of Directors has named Valentino Trubiani, Senior Partner at TSG Capital, Washington, D.C., as director, joining Paul Zuromski, Chairman and President, and Allison Cohen on the Board.

In his more than 12 years with TSG Capital, Mr. Trubiani has structured financing solutions utilizing the firm's proprietary Caesar Fund, providing debt-based funding for innovative, credit-worthy companies and consistent value for the Fund's members. Mr. Trubiani earned his MBA at Vanderbilt University's Graduate School of Management.

"Galea continues to make significant progress in the therapeutic nutritional marketplace, first with the increasing number of states that have added Nutraplete to their Medicaid reimbursement schedules, and with our ability to attract talented, experienced professionals such as Mr. Trubiani to our Board. Mr. Trubiani brings more than 30 years of finance experience to our Company," stated Mr. Zuromski.

"When I learned about Galea's efforts with Nutraplete, and the wide range of nutritional benefits it can bring to the HIV/AIDS community, I was eager to get involved and help bring this very important product to a wider range of exposure to the healthcare and investment communities," stated Mr. Trubiani.

Nutraplete is currently approved for Medicaid reimbursement in New York State, New Jersey, Connecticut, Illinois, Nevada and Washington State. The company is currently seeking Medicaid approval in California, Florida, Pennsylvania, Maryland, Washington, D.C. and other states. Nutraplete is distributed nationally by Allion Healthcare, Inc. (NASDAQ: ALLI) under its MOMS Pharmacy trade name.

About Nutraplete™

Nutraplete Therapeutic Drink Mix is the first therapeutic nutritional dietary supplement created specifically to help people living with HIV/AIDS. This multi-nutritional, therapeutic "functional food" includes pharmaceutical grade supplements that may provide health benefits by addressing common nutritional deficiencies. Nutraplete is available by prescription and approved by many state Medicaid pharmacy programs. For more information: www.nutraplete.com

Nutraplete is distributed exclusively in the U.S. by Allion Healthcare, Inc. (NASDAQ: ALLI) (www.allionhealthcare.com) under its MOMS Pharmacy trade name. MOMS Pharmacy is a specialty pharmacy that is focused exclusively on providing medications and support services to people living with HIV/AIDS. Visit www.momspharmacy.com.

About Galea Life Sciences, Inc.

Galea Life Sciences, Inc. focuses on the emerging field of advanced nutritional supplements designed to support traditional medical treatments and therapies, and specializes in the formulation, manufacturing, marketing and distribution of innovative dietary supplements that benefit people undergoing medical treatments and therapies. Nutraplete is its introductory product.


For more information about Galea or TSG Capital, please contact:
Robert Bleckman
Email Contact
202-388-4500, ext. 703
or
Paul Zuromski
President
Galea Life Sciences, Inc
877-576-8872

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES